EDGAR Filing Documents for 0001181431-15-008143

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001181431-15-008143

Filing Date

2015-06-10

Accepted

2015-06-10 20:28:38

Documents

Period of Report

2015-06-08

Document Format Files

Seq	Description	Document	Type	Size
1		rrd425589.html	4
1		rrd425589.xml	4	11542
	Complete submission text file	0001181431-15-008143.txt		12918

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269

Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 15924607